Atlas Trials

A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity

Clinical trial NCT05712642 · COMPLETED

Trial details

NCT number
NCT05712642
Sponsor
Cairo University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Retinopathy of Prematurity
Start date
2020-02-01
Primary completion
2020-12-30
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.